Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Maternal-Fetal Medicine · Antiphospholipid Syndrome

Pregnancy Planning and Obstetric APS Care

At a Glance

Most people with antiphospholipid syndrome can have healthy pregnancies when planning starts before conception and specialists coordinate care. Depending on clot history and antibody results, care may include low-dose aspirin, heparin, extra ultrasounds, and a postpartum blood-thinner plan.

For many people with Antiphospholipid Syndrome (APS), the journey to parenthood comes with extra layers of planning and medical care. While APS is a leading cause of treatable pregnancy complications, it is important to lead with this fact: with proactive medical management, the vast majority of people with APS can have successful, healthy pregnancies [1][2].

The Importance of Preconception Planning

If you have APS or carry the antibodies, the best time to start your pregnancy care is before you conceive. This allows your care team—which should include a Maternal-Fetal Medicine (MFM) specialist (a high-risk OB), a hematologist, and often a rheumatologist—to create a “blueprint” for your pregnancy [2][3].

During this planning phase, your doctors will:

  • Assess your “risk profile” based on whether you have a history of blood clots, previous pregnancy issues, or “triple-positive” antibodies [3].
  • Ensure your underlying health (like blood pressure) is stable [2].
  • Review your medications. If you are on Warfarin, you will need a plan to switch to Heparin, usually before conception or promptly after a positive pregnancy test under specialist supervision, as Warfarin exposure in early pregnancy is dangerous [4]. Never stop or change Warfarin independently.

Why the Switch to Heparin?

If you take Warfarin for APS, your doctor will transition you to Low-Molecular-Weight Heparin (LMWH), such as Lovenox, during pregnancy. This switch is standard because current guidelines strongly favor heparin-based treatments for the safety of the developing pregnancy [4][5]. Unlike Warfarin, Heparin does not cross the placenta, meaning it provides the necessary protection for you without directly affecting the baby [5].

Standard Care During Pregnancy

Once pregnant, the goal is to support the placenta—the organ that provides oxygen and nutrients to the baby—and prevent clots from forming in its delicate vessels [6]. Treatment depends on your history:

  1. Low-Dose Aspirin (LDA): Most patients start “baby aspirin” (81mg) before or during the first trimester to improve blood flow to the placenta [2][3].
  2. Heparin Injections:
    • Prophylactic Dose: A lower dose for those with only “obstetric APS” (history of pregnancy loss without prior clots) [3].
    • Therapeutic Dose: A higher, weight-adjusted dose for those with a history of blood clots [7][8].
    • Note: Asymptomatic aPL carriers do not automatically require heparin; management is individualized.
  3. Enhanced Monitoring: You will likely have more frequent ultrasounds than a standard pregnancy. Doctors use Doppler ultrasonography to measure blood flow through the uterine and umbilical arteries [9][10]. This helps them spot signs of “placental insufficiency” or fetal growth issues early [6][11].

Labor, Delivery, and the Postpartum Period

The “fourth trimester”—the weeks immediately after birth—is a critical time. The risk of blood clots is naturally higher after delivery, so your medication plan will continue [7].

  • Delivery Planning: Most APS patients do not need a routine induction unless there is a medical reason [2]. However, your care team will coordinate the timing of your last heparin dose so that you can safely receive an epidural or spinal anesthesia if needed [7].
  • Restarting Medication: You will typically restart Heparin after delivery according to a clinician-directed plan, based on delivery mode, bleeding status, and whether an epidural is present [2]. Do not self-administer based on general timetables. Patients with obstetric APS commonly require postpartum prophylaxis for six weeks, while prior thrombotic APS requires resumption of long-term anticoagulation. If you were on Warfarin before pregnancy, you will eventually transition back to it, usually under a “bridge” of heparin until your INR is stable [7].
  • Breastfeeding: Both Heparin and Warfarin are generally considered safe for use while breastfeeding, allowing you to maintain your protection while caring for your newborn [7].

Common questions in this guide

Can I have a healthy pregnancy if I have APS?
Most people with APS can have successful, healthy pregnancies when care is planned before conception and coordinated by specialists. Individual risk depends on clot history, previous pregnancy problems, antibody profile, and overall health.
Which specialists should manage an APS pregnancy?
A high-risk pregnancy team commonly includes a maternal-fetal medicine specialist, hematologist, and often rheumatologist, with an obstetrician or OB/GYN involved in pregnancy care. Ask your clinicians who will lead communication and medication decisions.
When should I switch from warfarin to heparin before pregnancy?
If you take warfarin for APS, your care team should plan a switch to low-molecular-weight heparin, such as Lovenox, before conception or promptly after a positive pregnancy test. Warfarin exposure can be dangerous in early pregnancy, so do not stop or change it without specialist guidance.
Does everyone with APS need heparin during pregnancy?
No. People with obstetric APS but no prior blood clot may receive a prophylactic dose, whereas a history of blood clots may call for therapeutic, weight-adjusted heparin. Asymptomatic antiphospholipid antibody carriers do not automatically need heparin; a specialist individualizes treatment.
How is the baby monitored during an APS pregnancy?
Monitoring commonly includes more frequent ultrasounds and Doppler ultrasound of the uterine and umbilical arteries. These checks help clinicians look for reduced placental blood flow, placental insufficiency, or fetal growth problems early.
How will my blood thinners be managed around labor and after birth?
APS alone usually does not require routine induction, but your team will time the last heparin dose around delivery so an epidural or spinal anesthetic can be considered safely. They will decide when to restart medication based on delivery type, bleeding, and any epidural. Obstetric APS commonly involves six weeks of postpartum prophylaxis, while prior thrombotic APS usually requires resuming long-term blood-thinner treatment.
Can I breastfeed while taking heparin or warfarin for APS?
Heparin and warfarin are generally considered safe while breastfeeding, so many people can continue protection while caring for their newborn. Confirm the medication and dose with your clinician, especially during the transition after delivery.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my specific antibody profile (single, double, or triple positive), what is my personalized risk for pregnancy complications?
  2. 2.When exactly should I switch from Warfarin to Heparin, and do I need to be on the 'prophylactic' or 'therapeutic' dose?
  3. 3.What is our specific schedule for growth scans and Doppler ultrasounds to monitor my placental health?
  4. 4.How will we manage my medications during labor and delivery to ensure I can safely have an epidural if I want one?
  5. 5.Who is the lead 'captain' of my care team—my OB/GYN, a Maternal-Fetal Medicine specialist, or my hematologist?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (11)
  1. 1

    Bleeding complications and antithrombotic treatment in 264 pregnancies in antiphospholipid syndrome.

    Yelnik CM, Lambert M, Drumez E, et al.

    Lupus 2018; (27(10)):1679-1686 doi:10.1177/0961203318787032.

    PMID: 30016929
  2. 2

    Obstetric antiphospholipid syndrome.

    Soto-Peleteiro A, Gonzalez-Echavarri C, Ruiz-Irastorza G

    Medicina clinica 2024; (163 Suppl 1()):S14-S21 doi:10.1016/j.medcli.2024.05.001.

    PMID: 39174149
  3. 3

    EULAR recommendations for the management of antiphospholipid syndrome in adults.

    Tektonidou MG, Andreoli L, Limper M, et al.

    Annals of the rheumatic diseases 2019; (78(10)):1296-1304 doi:10.1136/annrheumdis-2019-215213.

    PMID: 31092409
  4. 4

    Management of Women with Antiphospholipid Antibodies or Antiphospholipid Syndrome during Pregnancy.

    Lee EE, Jun JK, Lee EB

    Journal of Korean medical science 2021; (36(4)):e24 doi:10.3346/jkms.2021.36.e24.

    PMID: 33496084
  5. 5

    Warfarin and heparin monitoring in antiphospholipid syndrome.

    Mittal P, Sayar Z, Cohen H

    Hematology. American Society of Hematology. Education Program 2024; (2024(1)):192-199 doi:10.1182/hematology.2024000547.

    PMID: 39644000
  6. 6

    Pregnancy in antiphospholipid syndrome: what should a rheumatologist know?

    Andreoli L, Regola F, Caproli A, et al.

    Rheumatology (Oxford, England) 2024; (63(SI)):SI86-SI95 doi:10.1093/rheumatology/kead537.

    PMID: 38320595
  7. 7

    Diagnosis and management of antiphospholipid syndrome.

    Ahn Y, Hawkins C, Pearson E, Kubler P

    Australian prescriber 2024; (47(6)):179-185 doi:10.18773/austprescr.2024.055.

    PMID: 39777043
  8. 8

    Thrombosis and Anti-phospholipid Syndrome: a 5-Year Update on Treatment.

    Chighizola CB, Meroni PL

    Current rheumatology reports 2018; (20(7)):44 doi:10.1007/s11926-018-0741-5.

    PMID: 29850957
  9. 9

    EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome.

    Andreoli L, Bertsias GK, Agmon-Levin N, et al.

    Annals of the rheumatic diseases 2017; (76(3)):476-485 doi:10.1136/annrheumdis-2016-209770.

    PMID: 27457513
  10. 10

    Value of second-trimester uterine artery pulsatility index in pregnancies with systemic lupus erythematosus and/or antiphospholipid syndrome.

    Canto MJ, Ortiz-Santamaria V, Palau J, et al.

    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2022; (35(25)):6586-6592 doi:10.1080/14767058.2021.1918090.

    PMID: 33980112
  11. 11

    Antiphospholipid syndrome: An update on risk factors for pregnancy outcome.

    De Carolis S, Tabacco S, Rizzo F, et al.

    Autoimmunity reviews 2018; (17(10)):956-966 doi:10.1016/j.autrev.2018.03.018.

    PMID: 30118899

This page is for informational purposes only and does not constitute medical advice; pregnancy medications and monitoring for APS must be planned with your obstetrician and specialist care team.

Get notified when new evidence is published on familial antiphospholipid syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.